硬度计在系统性硬化症中的可靠性:系统综述与初步研究
本文通过PRISMA系统综述和初步研究评估硬度计在系统性硬化症(SSc)中的可靠性。系统综述仅纳入2项合格研究,初步研究显示评估者内信度优秀(ICC 0.78-0.99),评估者间信度良好至优秀(ICC 0.63-0.93),但足部较低(0.48和0.52)。结论支持硬度计的可靠性,但作为临床试验结局指标前需完全验证其评估皮肤纤维化的效度。
要点
- 系统综述仅2项研究符合条件,初步研究支持硬度计在SSc中的可靠性。
- 评估者内信度优秀(ICC 0.78-0.99),评估者间信度良好至优秀(ICC 0.63-0.93)。
- 足部评估者间信度较低(ICC 0.48和0.52),需谨慎解读。
核心结论
- 初步研究支持文献中硬度计在SSc患者中可靠的初步发现。
- 在将硬度计作为SSc临床试验的(附加)结局指标前,其评估皮肤纤维化的验证状态需完全证实。
研究设计与样本
- 系统综述按PRISMA指南识别所有评估硬度计在SSc中可靠性的原始研究。
- 初步研究第一队列74例SSc患者(61例女性,13例LSSc/53例LcSSc/8例DcSSc)评估评估者内信度。
- 第二队列30例SSc患者(21例女性,4例LSSc/20例LcSSc/6例DcSSc)评估评估者内和评估者间信度。
主要发现
- 系统综述仅识别出2篇独特记录符合条件以生成结论。
- Kissin报告2例DcSSc患者9个皮肤部位测量的评估者内信度ICC为0.86-0.94。
- Merkel和Kissin分别在5例DcSSc患者中描述6个和9个皮肤部位测量的评估者间信度ICC为0.82-0.96和0.61-0.85。
- 初步研究第一队列17个标准化皮肤部位评估者内信度ICC为0.93-0.99,第二队列为0.78-0.98。
- 初步研究17个标准化皮肤部位评估者间信度ICC为0.63-0.93,足部除外(0.48和0.52)。
关键数值与推荐
- 评估者内信度ICC优秀范围:系统综述0.86-0.94(2例DcSSc患者9个部位);初步研究第一队列0.93-0.99,第二队列0.78-0.98(17个标准化部位)。
- 评估者间信度ICC良好至优秀范围:系统综述0.82-0.96(5例DcSSc患者6个部位)和0.61-0.85(5例DcSSc患者9个部位);初步研究0.63-0.93(17个标准化部位),足部0.48和0.52。
临床怎么用
- 硬度计在SSc患者中显示出良好的评估者内和评估者间信度,可考虑用于临床评估皮肤硬度。
- 足部测量信度较低,临床解读足部硬度计结果时应谨慎。
- 在将硬度计纳入SSc临床试验结局指标前,需进一步完全验证其评估皮肤纤维化的效度。
局限性
- 系统综述仅识别出2项合格研究,证据基础有限。
- 初步研究样本量较小(第一队列74例,第二队列30例),可能影响结果的普遍性。
- 硬度计作为SSc皮肤纤维化评估工具的验证状态尚未完全确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the reliability of durometry in systemic sclerosis (SSc), by means of a systematic review and additional pilot study. METHODS: Literature was systematically reviewed according to the PRISMA guidelines to identify all original studies assessing the reliability of durometry in SSc. Additionally, in the pilot study, intra-rater reliability was evaluated in a first cohort of 74 SSc patients (61 female, 13 LSSc/53 LcSSc/8 DcSSc). In a second separate set of 30 SSc patients (21 female, 4 LSSc/20 LcSSc/6 DcSSc), intra- and inter-rater reliability were evaluated. RESULTS: Only two unique records identified through the systematic review were qualified to generate conclusions. Regarding intra-rater reliability, Kissin reported excellent intra-class correlation coefficient values (ICC, 0.86-0.94) for measurements at nine skin sites in two DcSSc patients. Merkel and Kissin described, both in five DcSSc patients, good to excellent inter-rater reliability (ICC, 0.82-0.96 and 0.61-0.85) for measurements at respectively, six and nine skin sites. In our pilot study, ICC for intra-rater reliability at 17 standardized skin sites were excellent in both cohorts, ranging 0.93-0.99 and 0.78-0.98, respectively. ICC for inter-rater reliability at 17 standardized skin sites were good to excellent 0.63-0.93, except for the feet (0.48 and 0.52). CONCLUSION: The preliminary findings in the literature are supported by our pilot study in which we have attested the reliability of durometry in SSc patients. However, prior to including durometry as an (additional) outcome measure in SSc clinical trials, its validation status in the assessment of skin fibrosis needs to be completely attested.
引用
- Vanhaecke A, Verschuere S, Vilela V, et al. Durometry in SSc: The hard facts. A systematic literature review and additional pilot study. Rheumatology (Oxford). 2021. PMID: 33493286. doi:10.1093/rheumatology/keab028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。